D.E. Shaw & Co’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-50,000
Closed -$1.63M – 3364
2016
Q2
$1.63M Sell
50,000
-50,000
-50% -$1.53M ﹤0.01% 2084
2016
Q1
$2.87M Buy
100,000
+88,276
+753% +$2.35M 0.01% 1628
2015
Q4
$392K Hold
11,724
– – ﹤0.01% 3224
2015
Q3
$333K Hold
11,724
– – ﹤0.01% 3302
2015
Q2
$475K Hold
11,724
– – ﹤0.01% 3186
2015
Q1
$577K Sell
11,724
-27,696
-70% -$1.28M ﹤0.01% 2963
2014
Q4
$1.79M Buy
+39,420
New +$1.55M ﹤0.01% 2359

Other funds holding AVNS

D.E. Shaw & Co's AVNS Position: Q3 2026 in Review

D.E. Shaw & Co sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 280,729 shares — an estimated $6.98M sold.

D.E. Shaw & Co first reported a position in AVNS in Q4 2014 and held it in 47 quarters. The position peaked at $30.1M in Q1 2022. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • D.E. Shaw & Co reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 280,729 Avanos Medical shares in Q3 2026, an estimated $6.98M.
  • D.E. Shaw & Co first reported a position in Avanos Medical in Q4 2014 and held it in 47 quarters.
  • D.E. Shaw & Co's Avanos Medical position peaked at $30.1M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.